Gilead Sciences, Inc.
ANTIVIRAL COMPOUNDS
Last updated:
Abstract:
The present disclosure provides a compound of Formula I: ##STR00001## which is useful in treating a variety of diseases, such as diseases caused by respiratory syncytial virus (RSV), HRV, hMPV, ebola, Zika, West Nile, Dengue, HCV and/or HBV infections.
Status:
Application
Type:
Utility
Filling date:
17 Feb 2021
Issue date:
16 Sep 2021